PortfoliosLab logoPortfoliosLab logo
EW vs. MTD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EW vs. MTD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Edwards Lifesciences Corporation (EW) and Mettler-Toledo International Inc. (MTD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EW achieves a 0.96% return, which is significantly lower than MTD's 1.59% return. Over the past 10 years, EW has underperformed MTD with an annualized return of 8.56%, while MTD has yielded a comparatively higher 13.47% annualized return.


EW

1D
-0.98%
1M
-8.80%
6M
5.79%
YTD
0.96%
1Y
8.50%
3Y*
1.61%
5Y*
-5.18%
10Y*
8.56%
ALL TIME*
17.35%

MTD

1D
2.59%
1M
8.24%
6M
3.14%
YTD
1.59%
1Y
18.30%
3Y*
3.31%
5Y*
-0.79%
10Y*
13.47%
ALL TIME*
17.43%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$480.40M$453.68M$434.27M
$267.15M$221.78M$258.42M

EW vs. MTD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EW
Edwards Lifesciences Corporation
0.96%15.16%-2.91%2.20%-42.41%42.00%17.32%52.31%35.90%20.29%
MTD
Mettler-Toledo International Inc.
1.59%13.93%0.88%-16.08%-14.83%48.92%43.67%40.26%-8.71%48.01%

Correlation

The correlation between EW and MTD is 0.25, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.25

Correlation (3Y)
Balances recent behavior with more history.

0.26

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.43

Correlation (10Y)
Provides a long-term view across more market conditions.

0.44

Correlation (All Time)
Calculated using the full available price history since Mar 27, 2000

0.36

The correlation between EW and MTD shifts across timeframes, from 0.25 (1 year) to 0.44 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

EW:

$49.56B

MTD:

$28.62B

EPS

EW:

$1.88

MTD:

$44.52

PE Ratio

EW:

45.90

MTD:

31.81

PEG Ratio

EW:

1.47

MTD:

4.88

PS Ratio

EW:

7.96

MTD:

6.97

PB Ratio

EW:

4.84

MTD:

7.76

Total Revenue (TTM)

EW:

$6.30B

MTD:

$4.13B

Gross Profit (TTM)

EW:

$4.92B

MTD:

$2.45B

EBITDA (TTM)

EW:

$1.44B

MTD:

$1.27B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EW vs. MTD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

EW
EW Risk / Return Rank: 5656
Overall Rank
EW Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
EW Sortino Ratio Rank: 5151
Sortino Ratio Rank
EW Omega Ratio Rank: 4949
Omega Ratio Rank
EW Calmar Ratio Rank: 6161
Calmar Ratio Rank
EW Martin Ratio Rank: 6161
Martin Ratio Rank

MTD
MTD Risk / Return Rank: 5757
Overall Rank
MTD Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
MTD Sortino Ratio Rank: 5555
Sortino Ratio Rank
MTD Omega Ratio Rank: 5656
Omega Ratio Rank
MTD Calmar Ratio Rank: 5757
Calmar Ratio Rank
MTD Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

EW vs. MTD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and Mettler-Toledo International Inc. (MTD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EWMTDDifference
Sharpe ratioReturn per unit of total volatility

-0.10

Sortino ratioReturn per unit of downside risk

-0.12

Omega ratioGain probability vs. loss probability

1.08

1.11

-0.03

Calmar ratioReturn relative to maximum drawdown

0.65

0.47

+0.18

Martin ratioReturn relative to average drawdown

1.51

1.16

+0.35

EW vs. MTD - Sharpe Ratio Comparison

The current EW Sharpe Ratio is 0.35, which is comparable to the MTD Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of EW and MTD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EW vs. MTD - Drawdown Comparison

The maximum EW drawdown since its inception was -54.32%, smaller than the maximum MTD drawdown of -61.43%. Use the drawdown chart below to compare losses from any high point for EW and MTD.


Loading charts...

Drawdown Indicators


EWMTDDifference

Max Drawdown

Largest peak-to-trough decline

-54.32%

-61.43%

+7.11%

Max Drawdown (1Y)

Largest decline over 1 year

-13.19%

-31.90%

+18.71%

Max Drawdown (3Y)

Largest decline over 3 years

-37.53%

-36.61%

-0.92%

Max Drawdown (5Y)

Largest decline over 5 years

-54.32%

-43.47%

-10.85%

Max Drawdown (10Y)

Largest decline over 10 years

-54.32%

-43.47%

-10.85%

Current Drawdown

Current decline from peak

-34.14%

-16.81%

-17.33%

Average Drawdown

Average peak-to-trough decline

-14.57%

-13.74%

-0.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.65%

12.81%

-7.16%

Volatility

EW vs. MTD - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 7.05%, while Mettler-Toledo International Inc. (MTD) has a volatility of 8.87%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than MTD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EWMTDDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.05%

8.87%

-1.82%

Volatility (6M)

Calculated over the trailing 6-month period

19.74%

27.24%

-7.50%

Volatility (1Y)

Calculated over the trailing 1-year period

24.34%

32.65%

-8.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.70%

32.43%

+0.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.23%

29.85%

+2.38%

Dividends

EW vs. MTD - Dividend Comparison

Neither EW nor MTD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

EW vs. MTD - Financials Comparison

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and Mettler-Toledo International Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

EW vs. MTD - Profitability Comparison

The chart below illustrates the profitability comparison between Edwards Lifesciences Corporation and Mettler-Toledo International Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.

MTD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Mettler-Toledo International Inc. reported a gross profit of 650.22M and revenue of 1.03B. Therefore, the gross margin over that period was 63.3%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.

MTD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Mettler-Toledo International Inc. reported an operating income of 309.34M and revenue of 1.03B, resulting in an operating margin of 30.1%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.

MTD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Mettler-Toledo International Inc. reported a net income of 232.90M and revenue of 1.03B, resulting in a net margin of 22.7%.


Frequently Asked Questions


EW and MTD have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MTD has higher volatility (8.87%) compared to EW (7.05%). In terms of maximum drawdown, EW dropped -54.32% vs MTD's -61.43%.

MTD currently has the higher Sharpe Ratio (0.46 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EW and MTD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer